ProCE Banner Activity

Key Viral Hepatitis Studies Influencing My Practice Following EASL 2022—Prof Stefan Zeuzem

Multimedia
Conference Coverage
Listen to expert insights on updates and new viral hepatitis data from EASL 2022, including data on investigational HBV agents, progress toward HBV cure, emerging treatments for HDV, HCV treatment implementation in treatment-experienced patients, and more.

Released: July 06, 2022

Expiration: July 05, 2023

No longer available for credit.

Share

Faculty

Stefan Zeuzem

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Stefan Zeuzem, MD: consulting fees: AbbVie, Gilead Sciences, Intercept, Janssen, Novo Nordisk, Sobi; fees for non-CME/CE services: AbbVie, Gilead Sciences, MSD.